Company shares are trading at $12.13 a bit higher than $11.35, the stock’s 50 day moving average and a great deal higher than the 200 day moving average of $10.24. The 50 day moving average was up by +6.90% and the 200 day average was up $1.89. Trading was light with 200K shares changing hands by the end of trading on Tuesday. Overall, volume was down 13.13% under the stocks normal daily volume.
Short traders are more bullish on shares of China Cord Blood Corporation lately as implied by the decrease in short interest. The company had a fall in short interest between September 29, 2017 and October 13, 2017 of -11.11%. Short shares decreased 27,736 over that period. The short-interest ratio decreased to 1.0 and the short interest percentage is 0.00% as of October 13.
The following firms have recently changed their position in CO. As of the end of the quarter Spark Investment Management LLC had bought a total of 84,100 shares growing its stake by 273.9%. The value of the investment in China Cord Blood Corporation increased from $204,000 to $1,088,000 a change of 433.3% quarter over quarter. As of quarter end Ubs Group Ag had disposed of 549 shares trimming its position 17.5%. The value in dollars went from $21,000 to $25,000 a change of $4,000 for the reporting period.
As of the end of the quarter Acadian Asset Management LLC had disposed of 528,501 shares trimming its holdings by 84.8%. The value of the investment in CO went from $5,904,000 to $1,051,000 decreasing 82.2% quarter to quarter. Parametrica Management Ltd grew its position by buying 289,203 shares an increase of 1,842.1% from 06/30/2017 to 09/30/2017. Parametrica Management Ltd now holds 304,903 shares with a value of $3,391,000. The value of the position overall is up by 2,175.8%.
China Cord Blood Corporation’s P/E ratio is 39.51 and the market cap of the company is 1.38B.
China Cord Blood Corporation, launched on April 10, 2006, is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The Company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. As of March 31, 2016, the Company had three operating cord blood banks in the Beijing municipality, the Guangdong province and the Zhejiang province, the People’s Republic of China..